As of November 2024 Theravance Biopharma has a market cap of $0.47 Billion USD. This makes Theravance Biopharma the world's 6774th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 21st, 2024 the market cap of Theravance Biopharma was reported to be: